Pacira Biosciences Inc
NASDAQ:PCRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
|
H
|
Healthpeak Properties Inc
F:HC5
|
US |
|
C
|
Cardinal Health Inc
XBER:CLH
|
US |
|
X
|
Xilio Therapeutics Inc
NASDAQ:XLO
|
US |
|
Meta Platforms Inc
BMV:META
|
US |
|
S
|
Sherwin-Williams Co
SWB:SJ3
|
US |
|
F
|
Fluor Corp
BMV:FLR
|
US |
|
S
|
SAP SE
XMUN:SAP
|
DE |
|
M
|
MTU Aero Engines AG
SWB:MTX
|
DE |
|
Relay Therapeutics Inc
NASDAQ:RLAY
|
US |
|
T
|
Tsingtao Brewery Co Ltd
XBER:TSI
|
CN |
Bankruptcy Probability
Pacira Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pacira Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
910m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pacira Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pacira Biosciences Inc has total debt of 367.7m USD. This includes both short-term (0 USD) and long-term (367.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
